Risk of Valuation Losses Due to Fluctuations in Investee Companies and Stock Markets
First written in FY2016. 16 of 31 entries say "Materialised", first in FY2016. Latest entry: 2026-08-04.
Dream Incubator moved to the "Worse" side of this theme in 2016, 4 years before the typical company in this theme (2020).
The whole theme swung hardest in 2019: 37 of 69 companies on the "Worse" side.
40 other companies' latest entry also says "Materialised".
- FY2026WorsenedAnnual report
「During the current fiscal year, we recorded a valuation loss of ¥50 million on operating investment securities (including unlisted shares and other securities).」
A valuation loss due to a decline in investee value actually occurred, and the valuation loss increased from ¥10 million in the previous fiscal year to ¥50 million. - FY2025MitigatedAnnual report
「During the current fiscal year, we recorded a valuation loss of ¥10 million on operating investment securities (including unlisted shares and other securities).」
Although a valuation loss due to a decline in investee value occurred, it fell sharply from the previous fiscal year’s ¥1,792 million valuation loss on operating investment securities to ¥10 million. - FY2025-H1WorsenedAnnual report
「Other comprehensive income Valuation difference on other securities 353 △ 134」
For the valuation difference on other securities, other comprehensive income was ¥353 million in the previous interim consolidated accounting period, compared with a negative ¥134 million in the current interim consolidated accounting period. - FY2024WorsenedAnnual report
「During the consolidated fiscal year, capital gains were realized through appropriate trade sales based on the medium-term management plan, while an impairment loss of ¥1,792 million was recorded due to declines in the value of 18 portfolio companies.」
A decline in investee value actually occurred, and the number of investees subject to impairment expanded from the most recent 9 to 18, while impairment losses increased to ¥1,792 million. - FY2024-Q3WorsenedAnnual report
「During the cumulative third quarter, we realized capital gains and other gains through trade sales, while recording an impairment loss of ¥831 million due to declines in the value of 9 portfolio companies.」
A decline in investee value actually occurred, and the number of investees subject to impairment expanded from certain investees in the previous fiscal year and the 3 most recent investees to 9, with impairment losses totaling ¥831 million. - FY2024-Q2MaterialisedAnnual report
「During the cumulative second quarter, we realized capital gains and other gains through trade sales, while also recording an impairment loss of ¥390 million due to declines in the value of 3 portfolio companies.」
Declines in the value of 3 investees actually occurred, and an impairment loss of ¥390 million was recorded. quantified is true, materialized is true. - FY2023MaterialisedAnnual report
「During the current fiscal year, we recorded a valuation loss of ¥469 million on operating investment securities (including unlisted shares and other securities) and an investment loss allowance provision of ¥10 million.」
A decline in investee value actually occurred during the current fiscal year as well, and a valuation loss of ¥469 million on operating investment securities and an investment loss allowance provision of ¥10 million were recorded. - FY2023-Q3RestatedAnnual report
「During the consolidated third quarter, we realized capital gains through multiple trade sales, while also recording impairment losses due to declines in the value of portfolio companies.」
Declines in investee value and the recording of impairment losses continued during the quarter. - FY2023-Q2MaterialisedAnnual report
「During the consolidated second quarter, we realized capital gains through multiple trade sales, while recording an impairment loss due to declines in the value of portfolio companies.」
A decline in investee value actually occurred during the second quarter of the current fiscal year as well, and an impairment loss was recorded. - FY2022MaterialisedAnnual report
「During the current fiscal year, we recorded valuation losses of ¥370 million on operating investment securities (unlisted shares) and ¥45 million on investment securities (unlisted shares).」
A decline in investee value actually occurred, and valuation losses of ¥370 million on operating investment securities and ¥45 million on investment securities were recorded. quantified is true, materialized is true. - FY2022-Q3Improved valuation differences; no impairment loss disclosedAnnual report
「Valuation difference on other securities 103 303」
The valuation difference on other securities increased from ¥103 million to ¥303 million. The performance discussion for the current quarter contains no disclosure of major impairment losses associated with declines in investee value, and the valuation difference improved. - FY2022-Q2Improved valuation differences; no major impairment lossesAnnual report
「The primary factors included an increase in the valuation difference on other securities due to fluctuations in the market value of held shares and foreign exchange rates.」
The valuation difference on other securities increased from ¥103 million to ¥208 million, while the valuation difference on other securities also improved from ¥390 million to ¥479 million. The disclosure states that no major impairment losses occurred during the first 2 quarters of the current fiscal year on a cumulative basis. - FY2021-Q3MaterialisedAnnual report
「During the first 3 quarters of the current fiscal year on a cumulative consolidated basis, we carried out sales through several trade sales and other transactions, while recording impairment losses and other items following declines in the value of 5 investees.」
Declines in the value of 5 investees actually occurred, and impairment losses and other items were recorded. The risk of valuation losses due to declines in investee value expanded from the previous quarter. - FY2021-Q2MaterialisedAnnual report
「During the first 2 quarters of the current fiscal year on a cumulative consolidated basis, we carried out sales through several trade sales and other transactions, while recording impairment losses and other items following declines in the value of 3 investees.」
Declines in the value of 3 investees actually occurred, and impairment losses and other items were recorded. - FY2021-Q1MaterialisedAnnual report
「Regarding existing venture investments, we provide funding and personnel at stages where our in-depth support is expected to accelerate growth, and subsequently proceed with exits. During the cumulative first quarter, we completed multiple exits through trade sales and other transactions, while recording an impairment loss on operating investment securities due to a decline in the value of 1 portfolio company.」
A decline in the value of one investee actually occurred, and an impairment loss on operating investment securities was recorded. - FY2020-Q3MaterialisedAnnual report
「Regarding existing venture investments, we provide funding and personnel at stages where our in-depth support is expected to accelerate growth, and subsequently proceed with exits. During the cumulative third quarter, in addition to multiple exits through trade sales, 1 portfolio company completed an IPO, while provisions for investment losses and other items were recorded due to declines in the value of 2 portfolio companies.」
Declines in the value of 2 investees actually occurred, and an investment loss allowance provision and other items were recorded. The risk of valuation losses due to declines in investee value materialized during the quarter as well. - FY2020-Q2MaterialisedAnnual report
「Regarding existing venture investments, we provide funding and personnel at stages where our in-depth support is expected to accelerate growth, and subsequently proceed with exits. During the cumulative second quarter, we completed multiple exits through trade sales and other transactions, while recording provisions for investment losses and other items due to declines in the value of 2 portfolio companies.」
Declines in the value of 2 investees actually occurred, and an investment loss allowance provision and other items were recorded. The valuation difference on other securities also decreased from negative ¥422 million at the end of March 2019 to negative ¥519 million. - FY2020-Q1WorsenedAnnual report
「Valuation difference on other securities △422 △534」
The valuation difference on other securities decreased from negative ¥422 million at the end of March 2019 to negative ¥534 million at the end of June 2019, increasing the impact of valuation changes caused by fluctuations in the market value of held shares and foreign exchange rates. - FY2019MaterialisedAnnual report
「For existing venture investees, we provide funding and personnel at stages where accelerated growth is expected through our intensive support, and proceed with sales thereafter. During the current fiscal year, in addition to sales through several trade sales, one investee completed an IPO, while we recorded valuation losses on operating investment securities and an investment loss allowance provision following declines in the value of 4 investees.」
Declines in the value of 4 investees actually occurred, and a valuation loss of ¥227 million on operating investment securities and an investment loss allowance provision of ¥92 million were recorded. - FY2019-Q3MaterialisedAnnual report
「For existing venture investees, we provide funding and personnel at stages where accelerated growth is expected through our intensive support, and proceed with sales thereafter. During the first 3 quarters of the current fiscal year on a cumulative basis, in addition to sales through several trade sales, one investee completed an IPO, while we recorded valuation losses on operating investment securities and an investment loss allowance provision following declines in the value of 2 investees.」
Declines in the value of 2 investees actually occurred, and valuation losses on operating investment securities and an investment loss allowance provision were recorded. The risk of valuation losses due to declines in investee value materialized during the quarter as well. - FY2019-Q1WorsenedAnnual report
「Valuation difference on other securities △308 △418」
The valuation difference on other securities decreased from negative ¥308 million at the end of March 2018 to negative ¥418 million at the end of June 2018, indicating a greater impact from valuation changes in held securities. - FY2018MaterialisedAnnual report
「The financial assets we hold, including securities, are primarily operating investment securities consisting of shares in listed and unlisted domestic companies, and these securities accounted for 31.9% of total assets in the consolidated financial statements at the end of the current fiscal year. These assets are exposed to internal risks, such as the business and financial risks of investee companies, and external risks, such as changes in market conditions for emerging-market equities, IPO reviews and regulations. Meanwhile, following declines in the value of 2 investees, we recorded impairment losses on operating investment securities.」
Operating investment securities accounted for 31.9% of total assets, and an impairment loss of ¥274 million was recorded following declines in the value of 2 investees. The risk of valuation losses and impairment losses actually materialized during the current fiscal year as well. - FY2018-Q3WorsenedAnnual report
「Valuation difference on other securities △90 △108」
The valuation difference on other securities decreased from negative ¥90 million at the end of the previous fiscal year to negative ¥108 million at the end of the third quarter, and the impact of valuation changes in held securities continued. - FY2018-Q2WorsenedAnnual report
「The primary factors included a decrease in the valuation difference on other securities due to declines in the market value of shares in listed venture companies in which we invest.」
The valuation difference on other securities decreased from negative ¥90 million at the end of the previous fiscal year to negative ¥167 million at the end of the second quarter, and valuation changes resulting from declines in the market value of shares in listed investees continued. - FY2018-Q1WorsenedAnnual report
「The primary factors included a decrease in the valuation difference on other securities due to declines in the market value of shares in listed venture companies in which we invest.」
A decline in the market value of shares in listed venture companies in which we invest actually occurred, and the valuation difference on other securities decreased from negative ¥90 million at the end of the previous fiscal year to negative ¥162 million. - FY2017-Q3MaterialisedAnnual report
「Meanwhile, following a decline in the value of one investee, we recorded an impairment loss on operating investment securities and an investment loss allowance provision.」
A decline in the value of one investee actually occurred, and an impairment loss on operating investment securities and an investment loss allowance provision were recorded. - FY2017-Q2WorsenedAnnual report
「Valuation difference on other securities △174 △334」
The valuation difference on other securities decreased from negative ¥174 million at the end of the previous fiscal year to negative ¥334 million at the end of the second quarter, indicating a greater impact from valuation changes in held securities. - FY2017-Q1WorsenedAnnual report
「The primary factor was a decrease in the valuation difference on other securities due to the impact of foreign exchange fluctuations on shares denominated in foreign currencies.」
Due to foreign exchange fluctuations affecting shares denominated in foreign currencies, the valuation difference on other securities decreased from negative ¥174 million at the end of the previous fiscal year to negative ¥493 million, indicating a greater impact from valuation changes. - FY2016MaterialisedAnnual report
「The financial assets we hold, including securities, are primarily operating investment securities consisting of shares in listed and unlisted domestic companies, and these securities accounted for 28.3% of total assets in the consolidated financial statements at the end of the current fiscal year. These assets are exposed to internal risks, such as the business and financial risks of investee companies, and external risks, such as changes in market conditions for emerging-market equities, IPO review processes and regulations. During the current fiscal year, we recorded a valuation loss of ¥418 million on operating investment securities (listed shares) and applied an investment loss allowance of ¥98 million.」
Operating investment securities accounted for 28.3% of total assets and were exposed to fluctuations in market conditions and other factors. A valuation loss of ¥418 million on listed shares was actually recorded.